Suppr超能文献

首例采用占位粒子治疗保留肾功能的腹膜后横纹肌肉瘤报告

First report of retroperitoneal rhabdomyosarcoma treated with space-making particle therapy for preservation of renal function.

作者信息

Tokuda Peter J K, Demizu Yusuke, Wang Tianyuan, Fukumitsu Nobuyoshi, Suzuki Takeshi, Kurihara Sho, Hiyama Eiso, Karakawa Shuhei, Kosaka Yoshiyuki, Sasaki Ryohei, Fukumoto Takumi, Kokubo Masaki, Soejima Toshinori

机构信息

Department of Radiation Oncology, Hyogo Ion Beam Medical Center Kobe Proton Center, 1-6-8 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047 Japan.

Department of Radiation Oncology, Kobe City Medical Center General Hospital, Kobe, Hyogo Japan.

出版信息

Int Cancer Conf J. 2024 Aug 10;13(4):476-480. doi: 10.1007/s13691-024-00712-3. eCollection 2024 Oct.

Abstract

Space-making particle therapy, which consists of surgical placement of a spacer followed by particle therapy, has become a solution to the problem of normal organs being exposed to a high radiation dose. A bioabsorbable spacer is particularly suitable for this purpose, but is not widely used. Surgical placement of a spacer is performed mostly to protect the digestive tract, but can also be used to protect the kidneys. Therefore, we have been interested in the use of space-making particle therapy to preserve renal function. A 14 month-old boy with intermediate-risk retroperitoneal rhabdomyosarcoma underwent surgery with placement of a bioabsorbable spacer following neoadjuvant chemotherapy and then received proton beam therapy of 41.4 Gy (relative biological effectiveness) in 23 fractions. In the 41 months since PBT, he has survived without local recurrence or signs of renal impairment. This report describes the first-ever case of surgical placement of a bioabsorbable spacer with the aim of preserving renal function during proton beam therapy. Space-making particle therapy is an innovative solution for peritoneal tumors adjacent to the kidneys.

摘要

空间制造粒子疗法,包括手术植入间隔物后进行粒子疗法,已成为解决正常器官受到高辐射剂量问题的一种方法。生物可吸收间隔物特别适合此目的,但尚未广泛使用。手术植入间隔物主要用于保护消化道,但也可用于保护肾脏。因此,我们一直对使用空间制造粒子疗法来保护肾功能感兴趣。一名14个月大的中度风险腹膜后横纹肌肉瘤男孩在新辅助化疗后接受了植入生物可吸收间隔物的手术,然后接受了23次分割的41.4 Gy(相对生物效应)质子束治疗。自质子束治疗后的41个月里,他存活下来,没有局部复发或肾功能损害的迹象。本报告描述了首例为在质子束治疗期间保护肾功能而手术植入生物可吸收间隔物的病例。空间制造粒子疗法是治疗肾脏附近腹膜肿瘤的一种创新解决方案。

相似文献

9
Rehabilitation for ankle fractures in adults.成人踝关节骨折康复。
Cochrane Database Syst Rev. 2024 Sep 23;9(9):CD005595. doi: 10.1002/14651858.CD005595.pub4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验